/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
0
0
mbrar
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
mbrar2023-08-25 05:53:572023-08-25 06:15:57Nura Bio Initiates Phase I Clinical Trial for its Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
0
0
mbrar
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
mbrar2022-09-13 18:26:242023-08-24 17:54:25Nura Bio reports preclinical data validating a conserved mechanism of inhibition of NAD hydrolases implicated in neurodegeneration in NEURON
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
0
0
mbrar
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
mbrar2022-09-13 18:11:412022-09-13 18:11:41Marc Freeman wins first annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
0
0
mbrar
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
mbrar2020-08-07 18:27:332020-08-07 18:27:33Nura Bio Announces publication of “Structural and Mechanistic Regulation of the Prodegenerative NAD Hydrolase SARM1” in CELL REPORTS
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
0
0
David Anderson
/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
David Anderson2020-07-29 04:00:122020-07-29 08:46:11Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing
